HER2 Positive Metastatic Breast Cancers
1 clinical trials · Condition
◉ Watch HER2 Positive Metastatic Breast Cancers
| Record | Firm | Date |
|---|---|---|
| A Study of Tucatinib (ONT-380) Combined With Capecitabine and/or Trastuzumab in Patients With HER2+ Metastatic Breast Cancer (NCT02025192) | Seagen Inc. | 2013-12-31 |
Track HER2 Positive Metastatic Breast Cancers automatically
Every clearance here is in the API, with alerts when new ones post.